July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
Princeton, New Jersey, April 25, 2012 – Sandoz today announced the introduction of enoxaparin sodium injection, USP 3 mL vials, a generic version of Sanofi's Lovenox® Injection Multiple-Dose Vials, in ...
Exposure to higher temperatures may have significantly impacted the efficacy of the recalled product. Sandoz has initiated a recall of 1 lot of Enoxaparin Sodium Injection, USP 40mg/0.4 mL single-dose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback